The store will not work correctly when cookies are disabled.
(R,S)N-Benzyl-4-hydroxy-2-morpholinobutanamide
ID: ALA1651902
PubChem CID: 51031627
Max Phase: Preclinical
Molecular Formula: C15H22N2O3
Molecular Weight: 278.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1ccccc1)C(CCO)N1CCOCC1
Standard InChI: InChI=1S/C15H22N2O3/c18-9-6-14(17-7-10-20-11-8-17)15(19)16-12-13-4-2-1-3-5-13/h1-5,14,18H,6-12H2,(H,16,19)
Standard InChI Key: XCZKTUAGFKNATC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
-0.6913 -13.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4072 -13.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4072 -14.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6913 -14.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0246 -13.7250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6913 -12.4875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5506 -12.4875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8347 -12.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1230 -12.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1230 -13.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8347 -13.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5506 -13.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0246 -14.5500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0246 -12.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0246 -11.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6913 -10.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6913 -10.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0246 -9.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7363 -10.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7363 -10.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
1 5 2 0
1 6 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
7 12 1 0
2 10 1 0
4 13 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
6 14 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.35 | Molecular Weight (Monoisotopic): 278.1630 | AlogP: 0.39 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.80 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.72 | CX LogP: 0.17 | CX LogD: 0.16 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: -1.07 |
References
1. Kulig K, Więckowski K, Więckowska A, Gajda J, Pochwat B, Höfner GC, Wanner KT, Malawska B.. (2011) Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors., 46 (1): [PMID:21111516] [10.1016/j.ejmech.2010.11.001] |